P. Provisions and Contingent Liabilities
Provisions: Provisions are recognised when there is a present obligation as a result of a past event, it is probable
that an outflow of resources embodying economic benefits will be required to settle the obligation and there is a
reliable estimate of the amount of the obligation. Provisions are measured at the best estimate of the expenditure
required to settle the present obligation at the Balance sheet date and are not discounted to its present value.
Contingent Liabilities: Contingent liabilities are disclosed when there is a possible obligation arising from past events,
the existence of which will be confirmed only by the occurrence or non occurrence of one or more uncertain future
events not wholly within the control of the company or a present obligation that arises from past events where it is
either not probable that an outflow of resources will be required to settle or a reliable estimate of the amount cannot
be made.
Q. Earnings Per Share
Basic earnings per share is calculated by dividing the net profit or loss for the period attributable to equity
shareholders by the weighted average number of equity shares outstanding during the period. Earnings considered
in ascertaining the Company’s earnings per share is the net profit for the period after deducting any attributable tax
thereto for the period. The weighted average number of equity shares outstanding during the period and for all
periods presented is adjusted for events, such as bonus shares, other than the conversion of potential equity shares,
which have changed the number of equity shares outstanding, without corresponding changes in resources. For the
purpose of calculating diluted earnings per share, the net profit or loss for the period attributable to equity
shareholders and the weighted average numbers of shares outstanding during the period is adjusted for the effects
of all dilutive potential equity shares.
R. Segment reporting
The Company operates in a single primary business segment. Hence, there are no reportable segment as per AS
17 Segment Reporting.
(ii) The Company has only one class of share capital namely Equity Shares having face value of ? 10 each.
(a) In respect of every equity share (whether fully paid or partly paid), voting right shall be in the same
proportion as the capital paid up on such equity share bears to the total paid up equity capital of the
Company.
(b) The dividend proposed by Board of Directors is subject to the approval of the shareholders in the ensuing
Annual General Meeting, except in case of interim dividend.
(c) In the event of liquidation, the shareholders of equity shares are eligible to receive the remaining assets
of the company after distribution of all preferential amounts, and due to creditors of the company in
proportion to their shareholdings.
(iii) Details of shares held by the holding company, the ultimate holding company, their subsidiaries and
associates: NIL
(v) Shares reserved for issue under options and contracts/commitments for the sale of shares/disinvestment,
including the terms and amounts: NIL
(vi) Terms of any securities convertible into equity/preference shares issued along with the earliest date of
conversion in descending order starting from the farthest such date: NIL
(vii) Calls unpaid (showing aggregate value of calls unpaid by Directors and officers): NIL
(viii) Forfeited shares (amount originally paid-up): NIL
(ix) Bonus Issue during Last five years - On July 06, 2022 Company has allotted 2940000 Bonus Shares in the
ratio of 14:1 i.e. for every 1 equity share 14 new equity shares were issued.
28.2 Statements of Account / balance confirmations, wherever received, have been reconciled and impact
thereof, if any, has been dealt with to the extent agreed up on by the Company. Claims or deductions, which
are not accepted by the Company, are treated as contingent liability and accounted for in the year of final
settlement.
28.3 In the opinion of management, the current assets, loans and advances have a value of realization in the
ordinary course of business, at least to the amount equal to the amount at which they are stated in the
Balance Sheet. The provision for all known liabilities is adequate and not in excess of what is required.
28.4 No dividends is proposed to be distributed to equity and preference shareholders for the period. There are
no arrears of fixed cumulative dividends on preference shares.
28.5 Amount raised through an issue of Equity Shares have been utilized for the purpose for which it was raised.
28.6 The borrowings from banks and financial institutions have been used for the purpose for which it was taken
at the balance sheet date.
28.7 In the opinion of the Board, all the assets other than Property, Plant and Equipment, Intangible assets and
non-current investments do have a value on realisation in the ordinary course of business at least equal to
the amount at which they are stated.
28.8 All the Immovable Property are held in name of the Company.
28.9 The Company has not revalued its Property, Plant and Equipment.
28.10 No Loans or Advances in the nature of loans are granted to promoters, directors, KMPs and the related
parties.
28.11 No proceedings have been initiated or pending against the company for holding any benami property under
the Benami Transactions (Prohibition) Act, 1988 (45 of 1988) and the rules made thereunder
28.12 The company has registered all the charges on its property within statutory time and no charge is pending
to be registered / modified / satisfied.
28.13 The Company has not entered into any transactions with struck off under section 248 of the Companies Act,
2013 or section 560 of Companies Act, 1956.
28.14 The company do not have any subsidiary Companies and accordingly, it is in compliance with the number
of layers prescribed under clause (87) of section 2 of the Act read with Companies (Restriction on number
of Layers) Rules, 2017.
28.16 The company do not have any Scheme of Arrangements has been approved by the Competent Authority in
terms of sections 230 to 237 of the Companies Act, 2013.
28.17 The company do not have advanced or loaned or invested funds (either borrowed funds or share premium
or any other sources or kind of funds) to any other person(s) or entity(ies), including foreign entities
(Intermediaries) with the understanding (whether recorded in writing or otherwise)
28.18 Disclosure of Long-Term Employee benefit
Note 30: Previous year's figures have been regrouped / reclassified wherever necessary to correspond with the
current year's classification / disclosure.
Signatures to Notes 1 to 30
For M/s A K Ostwal & Co, For and on behalf of the Board of
Chartered Accountants SPECIALITY MEDICINES LIMITED
FRN: 107200W
Parthkumar Goyani Sumit Goyani
Chairman & Managing Director Whole-time Director
(DIN: 07885789) (DIN: 07885780)
CA Amit M Ajagiya
Partner
M.No. 140574 Anita Kumawat
UDIN: 25140574BMGSID8896 Kalpesh Pipaliya Company Secretary
Date: 27/08/2025 Chief Financial Officer Membership No. A68535
Place: Surat Date: 27/08/2025 Place: Mumbai
|